Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: Jongmans who wrote (52)	5/31/2000 7:16:00 AM
From: scaram(o)uche	Respond to of 598

wow. (eom)

To: Jongmans who wrote (52)	5/31/2000 3:54:00 PM
From: tommysdad	Read Replies (2) \| Respond to of 598

The key question is: why? Why are they doing this? They are absolutely flush with cash from their IPO and their secondary, so they go partner up? JT is bringing nothing but cash to the table, gets half of any products, and has a buy-back option. What's in it for TLRK? They could have easily funded this themselves and owned it all. (Before someone responds with a "dilution of risk" answer, I submit that a company that takes an irreversible tubulin inhibitor into the clinic is quite comfortable with risk).